BDX
Becton, Dickinson And Co.

2,740
Loading...
Loading...
News
all
press releases
Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·1d ago
News Placeholder
More News
News Placeholder
BD & Henry Ford Health Tie-Up to Enhance Community Pharmacy Experience
BDX partners with Henry Ford Health to deploy BD Rowa Vmax robots, aiming to streamline 24/7 pharmacy access in Michigan.
Zacks·7d ago
News Placeholder
HOLX to Discontinue Fluoroscan InSight FD Soon: Will the Stock Suffer?
Hologic set to end sales of Fluoroscan InSight FD in 2025 but sees strong momentum from DXA systems and broader business growth.
Zacks·14d ago
News Placeholder
Here's Why Becton Dickinson (BDX) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·15d ago
News Placeholder
Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·20d ago
News Placeholder
Should Value Investors Buy Becton, Dickinson and Company (BDX) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·21d ago
News Placeholder
SOLV Strong Q2 Results Signal Momentum: Is the Stock Worth Buying Now?
Solventum beats on Q2 earnings, raises guidance, and powers ahead with transformation despite looming tariff headwinds.
Zacks·22d ago
News Placeholder
BDX vs. MMSI: Which Stock Should Value Investors Buy Now?
BDX vs. MMSI: Which Stock Is the Better Value Option?
Zacks·23d ago
News Placeholder
Hologic's 2025 Outlook Improves on Strong Q3, Easing Tariff Headwinds
HOLX lifts its 2025 revenue and EPS outlook on Q3 strength, tariff relief, and growth across Breast Health and GYN Surgical.
Zacks·28d ago
News Placeholder
Are Options Traders Betting on a Big Move in Becton Dickinson Stock?
Investors need to pay close attention to Becton Dickinson stock based on the movements in the options market lately.
Zacks·1mo ago

Latest BDX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.